Celularity Inc (NASDAQ: CELU)’s stock price has gone rise by 23.03 in comparison to its previous close of 1.52, however, the company has experienced a 10.65% increase in its stock price over the last five trading days. globenewswire.com reported 2025-05-09 that Net revenues for the year ending December 31, 2024, totaled $54.2 million, an increase of $31.4 million, or 138.1%, compared to the previous year. Net revenues for the year ending December 31, 2024, totaled $54.2 million, an increase of $31.4 million, or 138.1%, compared to the previous year.
Is It Worth Investing in Celularity Inc (NASDAQ: CELU) Right Now?
The stock has a 36-month beta value of 0.61. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CELU is 13.76M, and at present, short sellers hold a 12.18% of that float. On May 14, 2025, the average trading volume of CELU was 116.96K shares.
CELU’s Market Performance
CELU’s stock has seen a 10.65% increase for the week, with a 14.02% rise in the past month and a -5.08% fall in the past quarter. The volatility ratio for the week is 16.47%, and the volatility levels for the past 30 days are at 11.44% for Celularity Inc The simple moving average for the past 20 days is 16.08% for CELU’s stock, with a -16.59% simple moving average for the past 200 days.
Analysts’ Opinion of CELU
Many brokerage firms have already submitted their reports for CELU stocks, with Morgan Stanley repeating the rating for CELU by listing it as a “Underweight.” The predicted price for CELU in the upcoming period, according to Morgan Stanley is $1 based on the research report published on January 30, 2023 of the previous year 2023.
H.C. Wainwright gave a rating of “Buy” to CELU, setting the target price at $15 in the report published on June 22nd of the previous year.
CELU Trading at 17.31% from the 50-Day Moving Average
After a stumble in the market that brought CELU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.18% of loss for the given period.
Volatility was left at 11.44%, however, over the last 30 days, the volatility rate increased by 16.47%, as shares surge +10.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +59.83% upper at present.
During the last 5 trading sessions, CELU rose by +10.65%, which changed the moving average for the period of 200-days by -37.46% in comparison to the 20-day moving average, which settled at $1.6110. In addition, Celularity Inc saw -10.10% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CELU
Current profitability levels for the company are sitting at:
- -0.71 for the present operating margin
- 0.84 for the gross margin
The net margin for Celularity Inc stands at -1.32. The total capital return value is set at -0.49. Equity return is now at value -232.51, with -25.28 for asset returns.
Based on Celularity Inc (CELU), the company’s capital structure generated 0.77 points at debt to capital in total, while cash flow to debt ratio is standing at -0.22. The debt to equity ratio resting at 3.29. The interest coverage ratio of the stock is 6.12.
Currently, EBITDA for the company is -38.36 million with net debt to EBITDA at -0.44. When we switch over and look at the enterprise to sales, we see a ratio of 1.35. The receivables turnover for the company is 4.0for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.38.
Conclusion
To sum up, Celularity Inc (CELU) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
